These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 53808)

  • 41. Early phase components of the kallikrein kinin system in hemorrhagic ascitic fluid and plasma in the rat with induced acute pancreatitis.
    Seung WP; Feldman BF
    Am J Vet Res; 1985 Sep; 46(9):1961-6. PubMed ID: 2413790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism and significance of kinin formation in nephrotic syndrome.
    Nakamura K; Kazama M; Morioka M; Tahara C; Abe T
    Adv Exp Med Biol; 1986; 198 Pt B():253-62. PubMed ID: 3028075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prognosis of nephrosis].
    Habib R; Kleinknecht C; Gubler MC; Levy M; Guillot M; Gagnadoux MF; Broyer M
    Bol Med Hosp Infant Mex; 1981; 38(3):447-55. PubMed ID: 7271976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma.
    Briseid K; Johansen R; Rustenberg L
    Adv Exp Med Biol; 1979; 120B():101-12. PubMed ID: 517228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Physiopathology of kinin forming system in reproduction].
    Soga K; Maki M; Sasaki T; Motoyama Y
    Rinsho Ketsueki; 1989 Oct; 30(10):1713-22. PubMed ID: 2593238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Status of the kallikrein-kinin system, proteinase inhibitors and nonspecific resistance factors in patients with chronic kidney failure on hemodialysis as well as in kidney transplant recipients].
    Shcherbakova EG; Varakina NI; Iarovaia GA; Belorusov OS; Dotsenko VL; Vorob'eva LS
    Vopr Med Khim; 1991; 37(5):40-3. PubMed ID: 1722060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome.
    Trachtman H; Greenbaum LA; McCarthy ET; Sharma M; Gauthier BG; Frank R; Warady B; Savin VJ
    Am J Kidney Dis; 2004 Oct; 44(4):604-10. PubMed ID: 15384010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome.
    Hruby MA; Honig GR; Shapira E
    J Lab Clin Med; 1980 Sep; 96(3):501-10. PubMed ID: 6772722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atrial natriuretic factor in idiopathic minimal-lesion nephrotic syndrome.
    Garin EH; Paul RV
    Child Nephrol Urol; 1990; 10(2):65-7. PubMed ID: 2147579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The use of the kallikrein-kininogen system indices in the prognosis of the development of hemorrhagic erysipelas].
    Ambalov IuM; Levina LD; Aĭtkuluev NS; Kovalenko AP; Usatkin AV
    Lab Delo; 1991; (8):44-7. PubMed ID: 1724508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urine kallikrein excretion in relation to renal sodium handling in minimal change nephrotic syndrome.
    Ueda N; Niinomi Y; Nonoda T
    Clin Nephrol; 1991 Nov; 36(5):228-33. PubMed ID: 1752072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma prekallikrein/kallikrein processing by lysosomal cysteine proteases.
    Barros NM; Puzer L; Tersariol IL; Oliva ML; Sampaio CA; Carmona AK; Motta G
    Biol Chem; 2004 Nov; 385(11):1087-91. PubMed ID: 15576330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormonal regulation of glandular kallikrein activity and its inhibitor in human plasma.
    Koh H; Uchida K; Nambu S; Ikeda M
    Arzneimittelforschung; 1985; 35(4):735-7. PubMed ID: 2409987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of the kallikrein-kinin system in premature infants with respiratory distress syndrome (RDS).
    Saugstad OD; Harvie A; Langslet A
    Acta Paediatr Scand; 1982 Nov; 71(6):965-8. PubMed ID: 6925441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary kallikrein excretion in idiopathic nephrotic syndrome.
    Brouhard BH; Cunningham RJ; Petrusick TW; Berger M; Travis LB
    J Urol; 1979 May; 121(5):672-4. PubMed ID: 439267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of aprotinin and C1-esterase inhibitor on activation of the plasma kallikrein-kinin system in vivo.
    Hoffmann H; Siebeck M; Thetter O; Fink E; Philapitsch A
    Prog Clin Biol Res; 1987; 236A():159-64. PubMed ID: 2441405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hageman factor dependent pathway in local vascular permeability enhancement.
    Yamamoto T; Kozono K; Tsuruta J; Cochrane CG; Kambara T
    Adv Exp Med Biol; 1986; 198 Pt B():45-52. PubMed ID: 3812107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.